home
//
site map
//
search site
About
Company Overview
Management
Technology
Technology Overview
Clinical Applications
Research and Clinical Studies
News
Press Releases
Afferent In The News
Contact Us
Our lead technology enhances the function of mechanoreceptor cells involved in sensory perception as a means of restoring brain function following stroke, addressing complications resulting from diabetic neuropathy, and improving elderly balance.
Read More >>
Copyright 2007 Afferent Corporation. All rights reserved.